N-Nitroso Compounds in the Environment. Proceedings of a working conference held at the International Agency for Research on Cancer, Lyon, 1973 IARC Scientific Publication No. 9 (1975 .
Cancer embraces a wide variety of activity varying from epidemiology in general and occupational populations to the studies of th-e interactions of chemicals with DNA.
Since the discovery that dimethylnitrosamine was a potent carcinogen in experimental animals, much work has been generated based on the hypothesis that N-nitroso compounds may be a significant causative agent for cancer in humans. As a part of the major programme to examine this view the analytical question ' Are N-nitroso compounds present in the environment and if so, how did they get there? " is considered in this volume which is a report of a conference held at Lyon.
This volume contains three sections: analysis of N-nitroso compounds, formation of N-nitroso compounds and N-nitroso compounds in the environment. There are descriptions of methods which will allow the determination and identification of volatile nitrosamines and there are encouraging developments towards solving the more difficult problem of extraction and determination of non-volatile nitrosamines.
In the last two sections there is a variety of contributions which indicate the complexity of possible reactions of nitrites with exogenous and endogenous chemicals to yield nitrosamines. Substances are present in biological material which catalyse some of these reactions. Substances are also present which retard the reactions and it is clear that nitrosamines themselves are degraded in plants.
These observations no doubt will help us to move forward to understand the quantitative significance of nitrate and nitrite in the environment in relation to the possible production of carcinogenic nitrosamines.
On reading such reports of conferences I always have some reservations about their value. I am sure that the participants will have gained much from the meeting. (1975) .
Following an optimistic keynote" lecture by C. Gordon Zubrod, in which he outlined many of the problems in testing newN drugs, but at the same time placed in perspective the enormous field of study still available to the pharmacologist, the Bertner Foundation Award lecture by G. H.
Hitchings summarized the advances in the antifolates and pointed to future prospects in this field. Following a series of excellent and detailed articles on biotransformation of prednisolone, DIC, daunomycin and procarbazine by Loo and Johns, the kinetics of drug action with special reference to methotrexate activity was summarized by Zaharko. A conceptually useful contribution by Humphrey and Barranco contained summarized information relating to pharmacological principles, which was later exemplified by the demonstration of thymidine alleviation of methotrexate toxicity without interference with antitumour activity by Tattersall, Jaffe and Frei. A section of drug design was opened by a detailed and interesting review by Ahrens, followed bv a study of concepts of selectivity by Albert. A minor error in Fig. 9 , namely ICRF 145, should be noted. A most detailed structural approach to anti-cancer drug design was supported by C. C. Chang by a lengthy reference list, and biochemical pharmacology approaches to such drug design was summarized by Mead. Further quantitative structure activity studies were described by Hansche, Smith and Engle.
The widening field of prediction of antineoplastic activity was introduced by Venditti and provided ample material for subsequent papers by Bruce and Lau (cellular level), Hall, Kessel, Roberts, Nahas and Hacker (clinical level).
